Cancer BiologybioRxivPreprint
A TAK1Cytokine Toxicity Checkpoint Controls Anti-Cancer Immunity
Tirta Mario Djajawi, Anne Huber, S. Rivera…·Conor J. Kearney
This study identifies TAK1 as a cancer-intrinsic checkpoint that limits CD8+ T cell-mediated anti-cancer immunity by suppressing TNF and IFNγ-induced apoptosis, and shows that targeting TAK1 enhances anti-tumor responses.
DOI 10.1101/2025.05.09.652721